Why the study?
Acute ischemic stroke is a devastating complication of TAVR, but its impact on clinical outcomes, cost, and resource utilization has not been thoroughly studied.
What is the impact of post-TAVR acute ischemic stroke on in-hospital and 30-day morbidity, mortality, readmission rates, and cost?
Observational
Yes
What is the impact of post-TAVR acute ischemic stroke on in-hospital and 30-day morbidity, mortality, readmission rates, and cost?
Answers are grounded in this paper and cite their sources.
Post-TAVR stroke effects on short-term outcomes remain undefined in observational data; prospective studies needed to quantify risks and costs.
Acute ischemic stroke is a devastating complication of transcatheter aortic valve replacement (TAVR). Therefore, several studies have sought to investigate predictors of post-TAVR stroke,1,2 and to assess the potential role of cerebral embolic protection devices (EPDs) in reducing its incidence.3–5 However, the impact of post-TAVR stroke on clinical outcomes, cost, and resource utilization has not been thoroughly studied. We utilized a nationwide database to assess the impact of post-TAVR acute ischemic stroke on in-hospital and 30-day morbidity and mortality, readmission rates and cost.
No takes yet. Share an insight, caveat, or question.
Alqahtani et al. (2018) conducted an observational in Acute ischemic stroke following transcatheter aortic valve replacement (TAVR). Post-TAVR acute ischemic stroke was evaluated on In-hospital and 30-day morbidity and mortality, readmission rates and cost.
Synapse has enriched 10 related papers. Consider them for comparative context: